Treatment with antidepressant and anti-anxiety medications after breast cancer diagnosis in a large HMO. Background: Dermatologic toxicities (dT) to epidermal growth factor receptor inhibitors (EGFRI) ...
Reducing Treatment-Related Morbidity and Mortality in Early-Stage Hodgkin’s Disease and Why the Recent Southwest Oncology Group Trial Is Not the Way to Go PURPOSE: This is the first report on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback